Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation

Cancer Lett. 2011 Jul 1;306(1):76-84. doi: 10.1016/j.canlet.2011.02.034. Epub 2011 Mar 21.

Abstract

Notch signaling has been suggested to be required for many human cancers. However, the role of Notch signaling in human nasopharyngeal carcinoma cells (NPC) remains unknown. Here, we report that Notch-1, Notch-2, Notch-3 and Notch-4 are all detected in NPC cells. Notch inhibitor, GSI, suppresses the levels of Notch-1, Notch-2 and Notch-4, but not Notch-3. In addition, GSI inhibits NPC cell proliferation by inducing the cell cycle arrest and apoptosis. Furthermore, GSI inhibits the AKT and MEK signaling, without affecting P38 and JNK1/2. Thus, NPC cells may up-regulate Notch signaling to maintain cell proliferation and targeting the Notch signaling pathway may offer a potential alternative strategy for the treatment of NPC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid Precursor Protein Secretases / antagonists & inhibitors*
  • Apoptosis
  • Bisbenzimidazole / pharmacology
  • Carcinoma / metabolism*
  • Cell Cycle
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • DNA / genetics
  • Enzyme Inhibitors / pharmacology*
  • Fluorescent Dyes / pharmacology
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Membrane Potentials
  • Models, Biological
  • Nasopharyngeal Neoplasms / metabolism*
  • Receptors, Notch / metabolism*

Substances

  • Enzyme Inhibitors
  • Fluorescent Dyes
  • Receptors, Notch
  • DNA
  • Amyloid Precursor Protein Secretases
  • Bisbenzimidazole